Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

PaperCitations, authors & open-access status

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 169 citations, 2019 year and bronze oa status.

169
Citations
2019
Year
bronze
OA Status

Related on ScholarIQ

Francesco Facchinetti
Author
Benjamin Besse
Author
David Planchard
Author
Clinical Cancer Research
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account